Rowan University also named Dr. Mark Byrne as professor and inaugural chairman of the new department. A leader in the field of biomaterials engineering, controlled therapeutic delivery, pharmaceutical engineering, polymer engineering and medical devices, Byrne has won numerous awards for his teaching and research and has licensed a number of innovative technologies.
“Dr. Byrne has the education, experience and credentials to not only further develop and lead our new biomedical engineering program but also to nurture our student researchers in a very demanding and constantly evolving field,” said Dr. Anthony Lowman, dean of the College of Engineering. “His background is an excellent fit for a school that will continue to grow its focus on research.”
According to the New Jersey Business Magazine, “An inventor with eight issued patents and another four pending, Byrne is co-founder and chief technology officer of OcuMedic, Inc., a drug-delivery company in Auburn, Alabama. Numerous government agencies, including the National Institutes of Health, the National Science Foundation and U.S. Department of Education, have funded his research. He has published more than 75 peer-reviewed publications with more than1,500 citations and has given more than 210 scientific conference presentations and invited lectures at companies, universities and international meetings.”
“I am thrilled to build a nationally and internationally recognized program in biomedical engineering at Rowan,” Byrne said. “It is a tremendous opportunity, and we have ambitious plans to grow the undergraduate and graduate programs as well as conduct leading innovative research and teaching. The College of Engineering has some of the best faculty in the world, with tremendous commitment to novel education and research. It is a pleasure to join their prestigious, established programs in this period of unprecedented growth at Rowan. It is truly an exciting time to be at Rowan.”
For the complete story, click here.